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clinical microbiology laboratories to detect VISA and ESBL-producing pathogens; findings indicate that despite adequate capacity for proper testing, many laboratories do not have appropriate methodology to detect these resistant pathogens. A survey of laboratory practices was sent to the primary contact for participating ABCs/EIP Network laboratories during August-September 1998. Follow-up was con- Expanded screening to include special breakpoints for the three previously included antimicrobials, two cephalosporins (ceftazidime, cefpodoxime), and aztreonam, but also cefotaxime and ceftriaxone. 2.
Confirmatory testing methods for potential ESBLs-producing isolates of Klebsiella pneumoniae, K. oxytoca, and Escherichia coli by testing both cefotaxime and ceftazidime, alone and in combination with clavulanic acid. Testing can be performed by the broth microdilution method or by disk diffusion.
Reporting and interpretation:
Confirmed ESBL producers should be reported as resistant to all penicillins, cephalosporins (not including cephamycins such as cefoxitin and cefotetan), and aztreonam. Disk diffusion is not an acceptable method for vancomycin susceptibility testing of S. aureus. None of the known strains of S. aureus with reduced susceptiblity to vancomycin have been detected by this method (10 ).
3.
An MIC susceptibility testing method should be used to confirm vancomycin test results (6 ) .
Abortion Surveillance: Preliminary Analysis -United States, 1997
For 1997, CDC compiled data about legal induced abortions from the 50 states, New York City, and the District of Columbia. The total number of legal induced abortions was available from all reporting areas; however, not all these areas collected information about the characteristics of women who obtained abortions. This report presents preliminary data for 1997; final 1997 abortion data will be published during summer 2000.
In 1997, 1,184,758 legal induced abortions were reported to CDC (Table 1) , a decrease of 3.0% from 1996 (1 ) . The number of live births also decreased slightly (0.3% decrease) during the same period (2 ) . From 1996 to 1997, the number of reported abortions decreased in 34 of 52 reporting areas. The national abortion ratio (number of legal abortions per 1000 live births reported by all reporting areas) decreased from 314 in 1996 to 305 in 1997 (Table 1) , and the national abortion rate (number of legal abortions per 1000 women aged 15-44 years) remained at 20. Consistent with previous years, approximately 92% of women who had legal induced abortions were residents of the state in which the procedure was performed. Women who obtained legal abortions in 1997 were predominately white and unmarried. As in 1996, approximately 20% of women who obtained a legal abortion in 1997 were aged 19 years; 32% were aged 20-24 years.
Curettage (suction and sharp) remained the primary abortion procedure (98%); 18 reporting areas submitted information about abortions performed by medical (nonsurgical) procedures*. In 1997, 16 reporting areas reported 2988 medical procedures, and two states reported that medical procedures were included in the "other" category. As in previous years, more than half (approximately 55%) of legal abortions were per-*Medical abortions are nonsurgical procedures involving the administration of medication(s) to induce an abortion and are most frequently performed early in the first trimester of pregnancy (3 ) . The national ratio of legal induced abortions to live births indicates the number of abortions per 1000 live births. The national abortion ratio steadily declined each year from 1987 to 1995; in 1996, a slight increase in the ratio occurred; in 1997, the abortion ratio decreased and was at its lowest recorded level since 1975 (5 ) . Factors that might have contributed to the decline include a reduced number of unintended pregnancies, attitude changes concerning the decision to have an abortion or to carry a pregnancy to term, and reduced access to abortion services (6) (7) (8) .
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The decline in the abortion ratios also might be attributed to a shift in the age distribution of reproductive-aged women obtaining abortions. Although the actual number of women of reproductive age has increased by 2% since 1990, the proportion who are older (i.e., in later, less fertile reproductive years) also has increased. During 1990-1997, the percentage of reproductive-aged women in the highest fertility age group (<30 years) declined from 49% to 46% (Bureau of the Census, unpublished data, 1999), and the percentage in the lowest fertility age group (women aged 35-44 years) increased from 33% to 37% (2 ) .
For the first time in this report, medical (nonsurgical) procedures are included. Since the mid-1990s, medications (e.g., methotrexate and misoprostol) have been used by clinical practitioners to perform early medical abortions (9 ) . In 1997, the U.S. Standard Report of InducedTermination of Pregnancy, published by CDC's National Center for Health Statistics, was revised to include "Medical (Nonsurgical)," a new procedure category (3 ). In 1997, 18 states, New York City, and the District of Columbia included medical abortion procedures on their reporting forms. For the same year, 16 reporting areas submitted information to CDC about the number of performed medical abortions. However, the number reported to CDC may be an undercount; other researchers have estimated that approximately 4300 medical procedures were performed during the first half of 1997 (7 ) . During 1994 During -1995 
Shigellosis* Syphilis NETSS PHLIS (Primary & Secondary) Tuberculosis
N: Not notifiable U: Unavailable -: no reported cases *Individual cases may be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the Public Health Laboratory Information System (PHLIS). † Cumulative reports of provisional tuberculosis cases for 1999 are unavailable ("U") for some areas using the Tuberculosis Information System (TIMS). Food and Drug Administration (FDA) has found "approvable" for use as an abortifacient (FDA, personal communication, 1999) . Researchers expect that medical induced abortions will become more widespread if mifepristone is approved for use (7 ) . Since 1992, most reporting areas have reported abortions by gestational age in weeks of gestation for abortions performed at 8 weeks. As new medical methods are introduced and used for terminating pregnancies primarily at <8 weeks of gestation, these data will continue to assist in monitoring trends in legal abortions.
During 1997, the total numbers of legal induced abortions were available for each of the 52 reporting areas. However, approximately 32% of abortions were reported from states that in 1997 did not have annual centralized reporting of abortions (three states) or from states whose health departments could not provide information about characteristics (e.g., age or race) of women obtaining legal abortions (two states). To track efforts to prevent unintended pregnancy and changes in abortion practice, each state needs an accurate and ongoing assessment of abortion (including the number and characteristics of women obtaining legal abortions).
Previously published MMWRs that include statistical and epidemiologic information about abortion are available on the CDC World-Wide Web site, http://www.cdc.gov/ mmwr (1 ).
